What Corneal Staining Reveals About an Eye Under Stress
The cornea is transparent by design. That is essential for vision, but it can make early surface damage difficult to appreciate with the naked eye. Ocular surface staining gives clinicians a way to make some of that damage visible.
During an eye examination, a diagnostic dye such as fluorescein can be applied to the ocular surface. Under specialized illumination, areas where the corneal epithelium has been disrupted or compromised become easier to identify. What was nearly invisible can suddenly appear as a pattern of small stained areas across the surface.
In oGVHD, those patterns can tell part of the story of what happens when the eye’s protective systems begin to fail. The healthy cornea is protected by more than tears alone. The tear film must spread evenly, remain stable between blinks, reduce friction from the eyelids, support epithelial cells, and create an environment in which small injuries can repair themselves.
oGVHD can interfere with several of those functions at once. Lacrimal gland dysfunction may reduce tear volume. Meibomian gland abnormalities can increase evaporation. Conjunctival disease may impair mucin support. Inflammation can make the surface more vulnerable, while repeated blinking over an inadequately lubricated cornea can add mechanical stress.
Over time, the epithelium can begin to show the consequences. Staining therefore becomes more than a diagnostic technique. It is a visible record of a surface that is no longer being protected as effectively as it should be.
The amount and pattern of staining can help clinicians assess disease severity and follow changes over time. In clinical research, staining can also serve as an objective measure when investigators are trying to determine whether a therapy is improving the physical condition of the ocular surface.
But staining has its own limitations.
A heavily stained cornea does not tell clinicians exactly how much pain a patient is experiencing. Conversely, relatively modest staining does not mean symptoms must be mild. Ocular sensation is influenced by the dense network of nerves within the cornea, and symptoms can vary substantially between individuals.
That is why staining is most useful when it is treated as one layer of evidence rather than a final verdict.
For patients, the concept can help explain why an ophthalmologist may see clinically meaningful damage even when the eye simply “feels dry.” What the patient experiences as burning, grittiness, light sensitivity, or fluctuating vision may correspond to physical stress on the epithelial surface.
For researchers, staining provides something equally valuable: a way to ask whether treatment is doing more than temporarily changing sensation.
Is the cornea itself becoming healthier? In oGVHD, protecting the ocular surface is ultimately about preserving living tissue. Corneal staining allows some of that tissue stress to be seen.
This article is for educational purposes only and is not medical advice.
Sources:
- Wolffsohn JS, Arita R, Chalmers R, et al. “TFOS DEWS II Diagnostic Methodology Report.” The Ocular Surface, 2017.
https://www.tfosdewsreport.org/public/images/TFOS_DEWS_II_Diagnostic_method.pdf - Tappeiner C, Heiligenhaus A, Halter JP, et al. “Challenges and concepts in the diagnosis and management of ocular graft-versus-host disease.” Frontiers in Medicine, 2023.
https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2023.1133381/full - Nassiri N, Eslani M, Panahi N, et al. “Ocular Graft Versus Host Disease Following Allogeneic Stem Cell Transplantation.” Journal of Ophthalmic & Vision Research, 2013.
https://pmc.ncbi.nlm.nih.gov/articles/PMC3957042/
